Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells

Journal of Neuroscience Research

Volumn 46, Issue 5, 1996, Pages 595-605

  Scherer, Steven S ^a   Gutmann, David H ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

RhoA; schwannoma; schwannomin; tumor suppressor gene

Indexed keywords

GENE PRODUCT; POLYCLONAL ANTIBODY;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL FRACTIONATION; CELL LINE; CELLULAR DISTRIBUTION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; NERVE CELL GROWTH; NERVE GROWTH; NEUROFIBROMATOSIS; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; SCHWANN CELL; SCIATIC NERVE; TUMOR SUPPRESSOR GENE;

ANIMALS; CALCIUM; CELL ADHESION; CELL MEMBRANE; COS CELLS; CYTOSKELETON; DETERGENTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, NEUROFIBROMATOSIS 2; MEMBRANE PROTEINS; MICROFILAMENTS; NERVE TISSUE PROTEINS; NEUROFIBROMIN 2; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SCHWANN CELLS; SCIATIC NERVE; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TRANSFECTION;

EID: 0029851536     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19961201)46:5<595::AID-JNR8>3.0.CO;2-E     Document Type: Article

References (34)

1. Algrain M, Turunen O, Vaheri A, Louvard D, Arpin M (1993): Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol 120:129-139.
2. Birgbauer E, Dinsmore JH, Winckler B, Lander AD, Solomon F (1991): Association of ezrin isoforms with the neuronal cytoskeleton. J Neurosci Res 30:232-241.
3. Brockes JP, Fields P, Raff MC (1979): Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165:105-118.
4. Brockes JP, Lemke GE, Balzer DR Jr (1980): Purification and preliminary characterization of a glial growth factor from the bovine pituitary. J Biol Chem 255:8374-8377.
5. Brown MJ, Asbury AK (1981): Schwann cell proliferation in the postnatal mouse: Timing and topography. Exp Neurol 74:170-186.
6. den Bakker MA, Riegman PHJ, Hekman RACP, Coersma W, Janssen PJA, van der Kwast TH, Zwarthoff EC (1995a): The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells. Oncogene 10:757-763.
7. den Bakker MA, Tascilar M, Riegman PHJ, Hekman ACP, Boersma W, Janssen PJA, de Jong TAW, Hendricks W, van der Kwast TH, Zwarthoff EC (1995b): Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am J Pathol 147:1339-1349.
8. Einheber S, Milner T, Giancotti F, Salzer J (1993): Axonal regulation of Schwann cell integrin expression suggests a role for α6β4 in myelination. J Cell Biol 123:625-638.
9. Evans DGR, Huson SM, Donnai D, Neary W, Blair V, Newton V, Harris R (1992): A clinical study of type 2 neurofibromatosis. Q J Med 304:603-618.
10. Giordano MJ, Mahadeo DK, He YY, Geist RT, Hsu C, Gutmann DH (1996): Increased expression of the neurofibromatosis l (NF1) gene product, neurofibromin, in astrocytes in response to cerebral ischemia. J Neurosci Res 43:246-253.
11. Goslin, K, Birgbauer E, Banker G, Solomon F (1989): The role of cytoskeleton in organizing growth cones: A microfilament-associated growth cone component depends upon microtubules for its localization. J Cell Biol 109:1621-1631.
12. Gutmann DH, Wright DE, Geist RT, Snider WD (1995): Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development. Hum Mol Genet 4:471-478.
13. Knudson AG (1971): Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
14. Lutchman M, Rouleau GA (1995): The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res 55:2270-2274.
15. Martuza RL, Eldridge R (1988): Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Eng J Med 318:685-688.
16. McCartney BM, Fehon RG (1996): Distinct cellular and subcellular patterns of expression imply distinct functions for the Drosophila homologues of moesin and the neurofibromatosis 2 tumor suppressor, merlin. J Cell Biol 133:843-852.
17. Merel P, Hoang-Xuan K, Sanson M, Moreau-Aubry A, Bijisma EK, Lazaro C, Moisan JP, Resche F, Nishisho I, Estivill X, Delattre JY, Poisson M, Theillet C, Hulsebos T, Delattre O, Thomas G (1995): Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas. Genes Chromosom Cancer 13:211-216.
18. Mirsky R, Jessen KR (1990): Schwann cell development and the regulation of myelination. Semin Neurosci 2:423-435.
19. Pedraza L, Owens GC, Green LAD, Salzer JL (1990): The myelin-associated glycoproteins: Membrane disposition, evidence of a novel disulfide linkage between immunoglobulin-like domains, and posttranslational palmitylation. J Cell Biol 111:2651-2661.
20. Porter S, Clark MB, Glaser L, Bunge RP (1986): Schwann cells stimulated to proliferate in the absence of neurons retain full functional capability. J Neurosci 6:3070-3078.
21. Ridley AJ, Hall A (1992): The small GTP-binding protein rho regulates the assembly of focal adhesion and actin stress fibers in response to growth factors. Cell 70:389-399.
22. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk M, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijisma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldrige R, Aurias A, Delattre O, Thomas G (1993): Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-521.
23. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst SM (1994): Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 3:885-891.
24. Scherer SS (1996): Molecular specializations at nodes and paranodes in peripheral nerve. Microsc Res Tech 34:452-461.
25. Stahl N, Harry J, Popko B (1990): Quantitative analysis of myelin protein gene expression during development in the rat sciatic nerve. Mol Brain Res 8:209-212.
26. Takaishi K, Sasaki T, Kameyama T, Tsukita S, Tsukita S, Takai Y (1995): Translocation of activated RhoA from the cytoplasm to membrane ruffling area, cell-cell adhesion sites and cleavage furrows. Oncogene 11:39-48.
27. Takeuchi K, Sato N, Kasahara H, Funayama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S (1994): Perturbation of cell adhesion and microvilli formation by antisense oligonucleotides to ERM family members. J Cell Biol 125:1371-1384.
28. Thomas PK, Berthold C-H, Ochoa J (1993): Microscopic anatomy of the peripheral nervous system. In Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF (eds): "Peripheral Neuropathy," 3rd ed. Philadelphia: WB Saunders, pp 28-91.
29. Trapp BD Quarles, RH (1982): Presence of the myelin-associated glycoprotein correlates with alterations in the periodicity of peripheral myelin. J Cell Biol 92:877-882.
30. Trapp BD, Andrews SB, Wong A, O'Connell M, Griffin JW (1989): Co-localization of the myelin-associated glycoprotein and the microfilament components, F-actin and spectrin, in Schwann cells of myelinated nerve fibers. J Neurocytol 18:47-60.
31. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Haase VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF (1993): A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:1-20.
32. Twist EC, Ruttledge MH, Rouseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA (1994): The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151.
33. Zamboni L, de Martino C (1967): Buffered picric-acid formaldehyde: A new rapid fixative for electron-microscopy. J Cell Biol 35:148A.
34. Zhou J, Holtzman DM, Weiner RI, Mobley WC (1994): Expression of TrkA confers neuron-like responsiveness to nerve growth factor on an immortalized hypothalamic cell line. Proc Natl Acad Sci USA 91:3824-3828.